June 13, 2026 GBA Capital Management Strengthens Cross-Border Investment Partnerships Between Asia, the Middle East and Europe
June 13, 2026 Kos Biotechnology Partners Announces Third Closing of Global Life Sciences Fund at $123 Million
June 13, 2026 Lilly to present initial clinical data for first-in-class type II JAK2 inhibitor in patients with previously treated myelofibrosis at the 2026 EHA Annual Meeting
